Enter your email address
Submit
Write your message
Volume 12, Issue 4 (Iranian Quarterly Journal of Breast Disease 2020)
ijbd 2020, 12(4): 8-20 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Karamoozian M, Kalantari Khandani B, Bagheri M, Dehghanifar F, Darekordi A. Assessing Self-efficacy for Coping with Cancer: Psychometric Analysis of the Cancer Behavior Inventory (CBI). ijbd 2020; 12 (4) :8-20
URL: http://ijbd.ir/article-1-739-en.html
URL: http://ijbd.ir/article-1-739-en.html
Mahsa Karamoozian1 
, Behjat Kalantari Khandani2 , Masoud Bagheri * 3, Farzad Dehghanifar4 , Ali Darekordi5
, Behjat Kalantari Khandani2 , Masoud Bagheri * 3, Farzad Dehghanifar4 , Ali Darekordi5
1- Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
2- Dept of Oncology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
3- Dept of Psychology, University of Shahid Bahonar Kerman, Kerman, Iran
4- Ph.D. Student in Psychology, Dept of Psychology, Islamic Azad university of Zarand, Kerman, Iran
5- Dept of Psychology Payame Noor University of Kerman, Kerman, Iran
2- Dept of Oncology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
3- Dept of Psychology, University of Shahid Bahonar Kerman, Kerman, Iran
4- Ph.D. Student in Psychology, Dept of Psychology, Islamic Azad university of Zarand, Kerman, Iran
5- Dept of Psychology Payame Noor University of Kerman, Kerman, Iran
Abstract: (4741 Views)
Introduction: Self-efficacy refers to an individual’s belief in their capacity to execute a specific behavior. Believing that individuals themselves are responsible for their health can lead to the adoption of health behaviors. This study aimed to conduct a confirmatory factor analysis of a Cancer Behavior Inventory (CBI) for Iranian female breast cancer patients.
Methods: This was a descriptive-analytic study. First, we establishing the content and face validity of the instrument. Then, 345 breast cancer patients were selected from cancer treatment centers of Kerman city by convenience sampling to evaluate the psychometric properties of the instrument. The participants completed the CBI and the General Self-efficacy Scale. The instrument validity was assessed using exploratory and confirmatory factor analysis (structural validity) and correlational methods (concurrent validity), and the internal and external reliability were evaluated by calculating Cronbach’s alpha coefficients and using the test-retest method, respectively. Analyses were performed using SPSS 19 and AMOS software packages.
Results: Confirmatory factor analysis of the 31-item questionnaire, consisting of 7 subscales, was conducted after removing items 3 and 5. A significant correlation between each subscale and the General Self-efficacy Scale and also between the overall scale and the General Self-efficacy Scale confirmed the concurrent validity of the questionnaire. The reliability of the questionnaire was confirmed based on a Cronbach’s alpha coefficient value of 0.75 (ranging from 0.69 to 0.74 for the seven factors). The 1-month test-retest reliability, assessed by readministering the test to 30 cancer patients, ranged between 0.67 and 0.74 (P < 0.01), which shows acceptable reliability of the CBI over time.
Conclusion: The CBI has acceptable validity and reliability. The seven factors extracted for the CBI matched those identified in the original version. The present study introduces a tool that can be useful in assessing and evaluating the self-efficacy of breast cancer patients during treatment.
Methods: This was a descriptive-analytic study. First, we establishing the content and face validity of the instrument. Then, 345 breast cancer patients were selected from cancer treatment centers of Kerman city by convenience sampling to evaluate the psychometric properties of the instrument. The participants completed the CBI and the General Self-efficacy Scale. The instrument validity was assessed using exploratory and confirmatory factor analysis (structural validity) and correlational methods (concurrent validity), and the internal and external reliability were evaluated by calculating Cronbach’s alpha coefficients and using the test-retest method, respectively. Analyses were performed using SPSS 19 and AMOS software packages.
Results: Confirmatory factor analysis of the 31-item questionnaire, consisting of 7 subscales, was conducted after removing items 3 and 5. A significant correlation between each subscale and the General Self-efficacy Scale and also between the overall scale and the General Self-efficacy Scale confirmed the concurrent validity of the questionnaire. The reliability of the questionnaire was confirmed based on a Cronbach’s alpha coefficient value of 0.75 (ranging from 0.69 to 0.74 for the seven factors). The 1-month test-retest reliability, assessed by readministering the test to 30 cancer patients, ranged between 0.67 and 0.74 (P < 0.01), which shows acceptable reliability of the CBI over time.
Conclusion: The CBI has acceptable validity and reliability. The seven factors extracted for the CBI matched those identified in the original version. The present study introduces a tool that can be useful in assessing and evaluating the self-efficacy of breast cancer patients during treatment.
Full-Text [PDF 682 kb]
(2362 Downloads)
Conclusion: The CBI has acceptable validity and reliability. The seven factors extracted for the CBI matched those identified in the original version. The present study introduces a tool that can be useful in assessing and evaluating the self-efficacy of breast cancer patients during treatment.
Type of Study: Research |
Received: 2019/02/26 | Accepted: 2019/11/14 | Published: 2019/12/31
Received: 2019/02/26 | Accepted: 2019/11/14 | Published: 2019/12/31
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
